| scholarly article | Q13442814 |
| P50 | author | Robert Gallo | Q469904 |
| Barbara Ensoli | Q21255143 | ||
| P2093 | author name string | G Barillari | |
| R Gendelman | |||
| P2860 | cites work | Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS) | Q22242256 |
| A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin | Q24651246 | ||
| Integrins: versatility, modulation, and signaling in cell adhesion | Q27860844 | ||
| Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS | Q28262859 | ||
| Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90-kDa cell surface binding protein | Q28266812 | ||
| New perspectives in cell adhesion: RGD and integrins | Q28280381 | ||
| Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors | Q28645681 | ||
| Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS | Q29614260 | ||
| Adhesion receptors of the immune system | Q29616393 | ||
| The trans-activator gene of HTLV-III is essential for virus replication | Q34161962 | ||
| Activity of synthetic peptides from the Tat protein of human immunodeficiency virus type 1 | Q34306796 | ||
| The human immunodeficiency virus rev protein is a nuclear phosphoprotein | Q34534125 | ||
| The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome | Q34693731 | ||
| AIDS-associated Kaposi's sarcoma-derived cells in long-term culture express and synthesize smooth muscle alpha-actin | Q35831468 | ||
| The expression of endothelial cell surface antigens by AIDS-associated Kaposi's sarcoma. Evidence for a vascular endothelial cell origin | Q35835928 | ||
| Endocytosis and targeting of exogenous HIV-1 Tat protein | Q35926764 | ||
| Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins | Q36115020 | ||
| Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat | Q36223757 | ||
| T cell growth factor receptors. Quantitation, specificity, and biological relevance | Q36345824 | ||
| Control of intracellular pH and growth by fibronectin in capillary endothelial cells | Q36383431 | ||
| Dualistic nature of adhesive protein function: fibronectin and its biologically active peptide fragments can autoinhibit fibronectin function | Q36510361 | ||
| Cytoplasmic and transmembrane domains of integrin beta 1 and beta 3 subunits are functionally interchangeable | Q36530192 | ||
| Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation | Q36639380 | ||
| Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. | Q36680591 | ||
| Idiopathic production of interleukin-1 in acquired immune deficiency syndrome | Q37218877 | ||
| Laminin receptor on human breast carcinoma cells | Q37601668 | ||
| Pathogenesis of AIDS-associated Kaposi's sarcoma | Q37708279 | ||
| Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients | Q41734588 | ||
| Increased interferon-gamma and reduced hemoglobin in patients with human immunodeficiency virus type 1 infection | Q43608915 | ||
| Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis | Q43872292 | ||
| QBEnd/10: a new immunostain for the routine diagnosis of Kaposi's sarcoma | Q44109049 | ||
| Costimulation of proliferative responses of resting CD4+ T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin | Q44503153 | ||
| Neopterin: a predictive marker of acquired immune deficiency syndrome in human immunodeficiency virus infection. | Q45844620 | ||
| Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules | Q52107022 | ||
| Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells. | Q52833089 | ||
| AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. | Q54565305 | ||
| The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice | Q59060595 | ||
| Modulation of melanocyte intercellular adhesion molecule-1 by immune cytokines | Q68092981 | ||
| Heterogeneity for integrin expression and cytokine-mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteins | Q68198414 | ||
| Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome | Q68498654 | ||
| Antibodies to recombinant HIV-1 vif, tat, and nef proteins in human sera | Q68505483 | ||
| Elevated serum thymosin alpha 1 levels associated with evidence of immune dysregulation in male homosexuals with a history of infectious diseases or Kaposi's sarcoma | Q71726504 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| HIV/AIDS | Q12199 | ||
| virology | Q7215 | ||
| P304 | page(s) | 7941-5 | |
| P577 | publication date | 1993-09-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence | |
| P478 | volume | 90 |
| Q33954292 | A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H. |
| Q35133282 | AIDS - Associated Kaposi's Sarcoma: A Double Jeopardy |
| Q80510580 | AIDS-associated malignancies |
| Q59621919 | AIDS-associated malignancies |
| Q40925893 | AIDS-related Kaposi's sarcoma. A template for the translation of molecular pathogenesis into targeted therapeutic approaches |
| Q40427722 | AIDS: Viruses, cytokines and Kaposi's sarcoma |
| Q41418402 | Acquired immunodeficiency syndrome-associated Kaposi's sarcoma. Biology and management |
| Q58906184 | Activation of Endothelial Cell Mitogen Activated Protein Kinase ERK1/2by Extracellular HIV-1 Tat Protein |
| Q33948194 | Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor |
| Q33888277 | Adhesion receptors in health and disease |
| Q40915770 | Advances in Kaposi's sarcoma |
| Q48958311 | Altered outward-rectifying K(+) current reveals microglial activation induced by HIV-1 Tat protein |
| Q58281377 | An Emerging Impedance Sensor Based on Cell-Protein Interactions: Applications in Cell Biology and Analytical Biochemistry |
| Q90569887 | An Insight into the Angiogenic and Lymphatic Interplay in Pre-eclampsia Comorbid with HIV Infection |
| Q41118719 | An RGD containing peptide from HIV-1 Tat-(65-80) modulates protooncogene expression in human bronchoalveolar carcinoma cell line, A549. |
| Q33786008 | An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism |
| Q54338561 | Analysis of the effects of HIV-1 Tat on the survival and differentiation of vessel wall-derived mesenchymal stem cells. |
| Q28750291 | Angiogenesis, Kaposi's Sarcoma and Kaposi's Sarcoma-Associated Herpesvirus |
| Q34587184 | Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma |
| Q34267637 | Angiogenic properties of human immunodeficiency virus type 1 Tat protein |
| Q36226553 | Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17. |
| Q60671972 | Antiangiogenic, antitumoural and antimetastatic effects of two distamycin A derivatives with anti-HIV-1 Tat activity in a Kaposi's sarcoma-like murine model |
| Q28267535 | Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G |
| Q38576959 | Beyond RGD: virus interactions with integrins. |
| Q34292002 | Biology of Kaposi's sarcoma |
| Q44541953 | Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time |
| Q40849559 | Cell adhesion molecules |
| Q40806871 | Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application. |
| Q39776511 | Characterization of entry mechanisms of human herpesvirus 8 by using an Rta-dependent reporter cell line. |
| Q47344080 | Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists |
| Q35174141 | Clinical presentations and standard therapy of AIDS-associated Kaposi's sarcoma |
| Q38022377 | Comparative nucleic acid chaperone properties of the nucleocapsid protein NCp7 and Tat protein of HIV-1. |
| Q59511395 | Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine |
| Q35033232 | Cytokine therapeutics: lessons from interferon alpha |
| Q34209585 | Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. |
| Q30445016 | Detection of Kaposi's sarcoma-associated herpesvirus-like DNA sequence in angiosarcoma |
| Q42933098 | Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking |
| Q37858935 | Emerging topics in human tumor virology |
| Q36563605 | Endothelial cells and cathepsins: Biochemical and biomechanical regulation |
| Q42168186 | Evidence of protein transduction but not intercellular transport by proteins fused to HIV tat in retinal cell culture and in vivo |
| Q28291464 | Exogenous human immunodeficiency virus type-1 Tat protein selectively stimulates a phosphatidylinositol-specific phospholipase C nuclear pathway in the Jurkat T cell line |
| Q37988482 | Exploring transduction mechanisms of protein transduction domains (PTDs) in living cells utilizing single-quantum dot tracking (SQT) technology |
| Q45625995 | Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat. |
| Q34425378 | Extracellular HIV Tat and Tat cysteine rich peptide increase CCR5 expression in monocytes |
| Q28256170 | Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells |
| Q36489766 | Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey |
| Q24683736 | Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes |
| Q35294664 | Fibroblast Growth Factor-2 and the HIV-1 Tat Protein Synergize in Promoting Bcl-2 Expression and Preventing Endothelial Cell Apoptosis: Implications for the Pathogenesis of AIDS-Associated Kaposi's Sarcoma |
| Q42007452 | Fibronectin modulates the effects of HIV-1 Tat on the growth of murine Kaposi's sarcoma-like cells through the down-regulation of tyrosine phosphorylation |
| Q35779848 | Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death |
| Q30053318 | Gene expression profiles and protein–protein interaction network analysis in AIDS patients with HIV-associated encephalitis and dementia |
| Q60946881 | HIV Proteins and Endothelial Dysfunction: Implications in Cardiovascular Disease |
| Q35088029 | HIV Tat, its TARgets and the control of viral gene expression |
| Q34115364 | HIV-1 Nef and KSHV oncogene K1 synergistically promote angiogenesis by inducing cellular miR-718 to regulate the PTEN/AKT/mTOR signaling pathway |
| Q59357751 | HIV-1 TAT-mediated microglial activation: role of mitochondrial dysfunction and defective mitophagy |
| Q39215152 | HIV-1 Tat Binding to PCAF Bromodomain: Structural Determinants from Computational Methods |
| Q35668299 | HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway. |
| Q47217828 | HIV-1 Tat increases the adhesion of monocytes and T-cells to the endothelium in vitro and in vivo: implications for AIDS-associated vasculopathy |
| Q34542341 | HIV-1 Tat promotes Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K/PTEN/AKT/GSK-3β signaling pathway |
| Q46830857 | HIV-1 Tat raises an adjuvant-free humoral immune response controlled by its core region and its ability to form cysteine-mediated oligomers |
| Q24541552 | HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway |
| Q30381447 | HIV-1 Tat-based vaccines: an overview and perspectives in the field of HIV/AIDS vaccine development. |
| Q33641330 | HIV-1 inhibits autophagy in bystander macrophage/monocytic cells through Src-Akt and STAT3. |
| Q34477471 | HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies |
| Q33760273 | HIV-1-trans-activating (Tat) protein: both a target and a tool in therapeutic approaches |
| Q77723670 | HIV-I Tat: a polypeptide for all seasons |
| Q36986644 | HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial |
| Q37746717 | Human endothelial cells enhance human immunodeficiency virus type 1 replication in CD4+ T cells in a Nef-dependent manner in vitro and in vivo |
| Q39733480 | Human herpesvirus 8 envelope glycoprotein B mediates cell adhesion via its RGD sequence |
| Q34976938 | Human herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immunodeficiency virus type 1 Tat. |
| Q24523677 | Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells. |
| Q37478613 | Human immunodeficiency virus type 1 Tat accelerates Kaposi sarcoma-associated herpesvirus Kaposin A-mediated tumorigenesis of transformed fibroblasts in vitro as well as in nude and immunocompetent mice |
| Q43920738 | Human immunodeficiency virus type 1 Tat binds to Candida albicans, inducing hyphae but augmenting phagocytosis in vitro |
| Q35857699 | Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes |
| Q28182166 | Human immunodeficiency virus type 1 tat-mediated cytotoxicity of human brain microvascular endothelial cells |
| Q41974606 | Human immunodeficiency virus-1 tat induces hyperproliferation and dysregulation of renal glomerular epithelial cells |
| Q35856188 | Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic |
| Q35773554 | Immunihistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma. |
| Q35745497 | Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells |
| Q47606258 | Infection of KSHV and Interaction with HIV: The Bad Romance |
| Q22253931 | Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat |
| Q36915824 | Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors |
| Q33890579 | Interaction of HIV-1 Tat with Puralpha in nuclei of human glial cells: characterization of RNA-mediated protein-protein binding |
| Q40967561 | Interaction of the transactivating protein HIV-1 tat with sulphated polysaccharides |
| Q34354735 | Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma |
| Q38310502 | Intracellular HIV-Tat expression induces IL-10 synthesis by the CREB-1 transcription factor through Ser133 phosphorylation and its regulation by the ERK1/2 MAPK in human monocytic cells. |
| Q35784760 | Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling. |
| Q33799971 | Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication |
| Q27487405 | Kaposi's Sarcoma-Associated Herpesvirus Forms a Multimolecular Complex of Integrins ( V 5, V 3, and 3 1) and CD98-xCT during Infection of Human Dermal Microvascular Endothelial Cells, and CD98-xCT Is Essential for the Postentry Stage of Infection |
| Q74292311 | Kaposi's sarcoma |
| Q61641140 | Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents |
| Q34191778 | Kaposi's sarcoma: aetiopathogenesis, histology and clinical features |
| Q73412387 | Levels of the bcl-2 protein, fibronectin and alpha(5)beta(1) fibronectin receptor in HIV-1-infected patients with Kaposi's sarcoma |
| Q39577503 | Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. |
| Q33889326 | Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon |
| Q35879801 | Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. |
| Q35026060 | Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis |
| Q35020357 | Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism. |
| Q35606725 | Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia |
| Q42791604 | Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors and dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice. |
| Q28261344 | Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions |
| Q61641127 | NOVEL STRATEGIES TOWARD THE DEVELOPMENT OF AN EFFECTIVE VACCINE TO PREVENT HUMAN IMMUNODEFICIENCY VIRUS INFECTION OR ACQUIRED IMMUNODEFICIENCY VIRUS* |
| Q40941958 | New concepts in the immunology of sickle cell disease |
| Q33808225 | Novel Tat-encoding bicistronic human immunodeficiency virus type 1-based gene transfer vectors for high-level transgene expression |
| Q34579037 | Novel biopanning strategy to identify epitopes associated with vaccine protection |
| Q37547409 | Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication |
| Q41175493 | Pathogenesis of AIDS--related Kaposi's sarcoma. Evidence of a viral etiology |
| Q40812571 | Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat. |
| Q33724002 | Perspective on Kaposi's sarcoma: facts, concepts, and conjectures |
| Q24684750 | Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication |
| Q37224899 | Plasma gelsolin accumulates in macrophage nodules in brains of simian immunodeficiency virus infected rhesus macaques |
| Q30879123 | Potent inhibition of HIV-1 replication by a Tat mutant |
| Q36546999 | Professional antigen presenting cells in human herpesvirus 8 infection |
| Q74349433 | RGD sequences in several receptor proteins: novel cell adhesion function of receptors? |
| Q36135122 | Recent insights into the pathogenesis of Kaposi's sarcoma |
| Q36489392 | Reciprocal transactivation between HIV-1 and other human viruses |
| Q35866513 | Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture. |
| Q45784866 | Recombinant human immunodeficiency virus type-1 (HIV-1) Tat protein sequentially up-regulates IL-6 and TGF-beta 1 mRNA expression and protein synthesis in peripheral blood monocytes |
| Q37519397 | Role of Tat protein in HIV neuropathogenesis |
| Q39023036 | Selective up-regulation of functional CXCR4 expression in erythroid cells by HIV-1 Tat protein |
| Q39797374 | Single particle tracking confirms that multivalent Tat protein transduction domain-induced heparan sulfate proteoglycan cross-linkage activates Rac1 for internalization |
| Q40910553 | Stable gene transfer to the nervous system using a non-primate lentiviral vector |
| Q47356366 | Strong T cell type-1 immune responses to HIV-1 Tat (1-72) protein-coated nanoparticles |
| Q77103107 | Summary of the III International Consensus Symposium on Combined Antiviral Therapy |
| Q41435232 | Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma |
| Q28214887 | Tat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replication |
| Q35993736 | Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine |
| Q33785321 | Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains |
| Q24683211 | Tat protein induces self-perpetuating permissivity for productive HIV-1 infection |
| Q58831684 | Tat-induced platelet-activating factor synthesis contributes to the angiogenic effect of HIV-1 Tat |
| Q34755910 | Tat-neutralizing antibodies in vaccinated macaques |
| Q40200860 | The Evolving Profile of the Signature Amino Acid Residues in HIV-1 Subtype C Tat. |
| Q47105912 | The Rho ADP-ribosylating C3 exoenzyme binds cells via an Arg-Gly-Asp motif |
| Q40618025 | The Tat protein of the human immunodeficiency virus type 1 (HIV-1) interacts with the EGF-like repeats of the Notch proteins and the EGF precursor |
| Q43822559 | The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists |
| Q33974601 | The basic domain of HIV-tat transactivating protein is essential for its targeting to lipid rafts and regulating fibroblast growth factor-2 signaling in podocytes isolated from children with HIV-1-associated nephropathy |
| Q37364423 | The effects of HIV Tat DNA on regulating the immune response of HIV DNA vaccine in mice |
| Q54235978 | The evolution of subtype B HIV-1 tat in the Netherlands during 1985-2012. |
| Q45764762 | The human immunodeficiency virus type-1 (HIV-1) Tat protein and Bcl-2 gene expression |
| Q38292349 | The human immunodeficiency virus-1 Tat protein activates human umbilical vein endothelial cell E-selectin expression via an NF-kappa B-dependent mechanism |
| Q48485626 | The immunophilin ligand GPI1046 protects neurons from the lethal effects of the HIV-1 proteins gp120 and Tat by modulating endoplasmic reticulum calcium load |
| Q38248404 | The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma |
| Q35174147 | Therapy of AIDS-associated Kaposi's sarcoma: targeting pathogenetic mechanisms |
| Q37825906 | Tits and bits of HIV Tat protein. |
| Q35024694 | Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein |
| Q35035928 | Transport of exogenous growth factors and cytokines to the cytosol and to the nucleus |
| Q28580077 | Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands |
| Q35215799 | Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth |
| Q45012988 | Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P). |
| Q35114827 | Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques |
| Q33846198 | Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease |
| Q45422129 | Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques |
| Q37220038 | What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? |
| Q38615044 | alphavbeta3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells |
Search more.